Gilead Sciences Pty Ltd v Idenix Pharmaceuticals LLC [2016] FCA 169

Gilead Sciences Pty Ltd v Idenix Pharmaceuticals LLC [2016] FCA 169

The Court held that claims 7 and dependent claims of the Idenix patent were invalid for insufficiency (failure to enable a person skilled in the art to make the claimed compounds without new inventions or prolonged study) and inutility (to the extent claims covered compounds that could not be made, e.g., those with certain halogen substituents at the 2' position). However, other grounds of invalidity (lack of novelty, lack of internal/external fair basis, manner of manufacture, false suggestion) were not established. The claims were entitled to the priority date of the 949 application, so novelty was preserved over the Clark patent.

Jurisdiction
Australia
Judgment Date
02 March 2016
Procedural Posture
Patent Proceedings / First Instance Judgment
Outcome
Applicant partially successful—Idenix patent held invalid to the extent of claims lacking sufficiency and utility; other grounds rejected.
Legal Topics
['patents' 'sufficiency' 'novelty' 'utility' 'fair Basis' 'false Suggestion' 'manner of Manufacture']
['intellectual Property'] ['patents' 'sufficiency' 'novelty' 'utility' 'fair Basis' 'false Suggestion' 'manner of Manufacture']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Patent Proceedings / First Instance Judgment

Legal Issues

  1. 1 ["Whether claims of Idenix's patent are entitled to claimed priority dates (novelty)" 'Whether claims are fairly based on the specification (internal fair basis)' 'Whether the patent enables a skilled addressee to produce the invention without undue effort (sufficiency)' 'Whether the claims are useful (utility)' 'Whether the invention claimed is a manner of manufacture' 'Whether the patent was obtained by false suggestion']

Ratio Decidendi

The Court held that claims 7 and dependent claims of the Idenix patent were invalid for insufficiency (failure to enable a person skilled in the art to make the claimed compounds without new inventions or prolonged study) and inutility (to the extent claims covered compounds that could not be made, e.g., those with certain halogen substituents at the 2' position). However, other grounds of invalidity (lack of novelty, lack of internal/external fair basis, manner of manufacture, false suggestion) were not established. The claims were entitled to the priority date of the 949 application, so novelty was preserved over the Clark patent.

Court Disposition

Applicant partially successful—Idenix patent held invalid to the extent of claims lacking sufficiency and utility; other grounds rejected.

Orders

  • ['The parties are to confer and file agreed or competing orders reflecting these reasons within 14 days. Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.']